Vimarsana
Biggest News Aggregation in the World

Page 9 - River Blindness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from River Blindness. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In River Blindness Today - Breaking & Trending Today

How Anambra govt is responding to NTDs – Official - Vimarsana News

How Anambra govt is responding to NTDs – Official

“About 16 LGAs are endemic for River Blindness, 21 LGAs are endemic for Elephantiasis, 11 LGAs are endemic for Schistosomiasis and 12 LGAs are endemic for Soil-Transmitted Helminthiasis.”

Clinical Trial Begins for New Drug to Combat Neglected Tropical Diseases - Vimarsana News

Clinical Trial Begins for New Drug to Combat Neglected Tropical Diseases

UK researchers have begun the first clinical trial of a novel drug candidate against the neglected tropical diseases, lymphatic filariasis and onchocerciasis.

Like the Chinese Communist Party, Big Tech Disappears Doctors - Vimarsana News

Like the Chinese Communist Party, Big Tech Disappears Doctors

At the beginning of the Wuhan coronavirus pandemic, a number of doctors in China sounded the alarm about an unknown, pneumonia-like virus sweeping through the country. Ultimately, it would reach

Like the Chinese Communist Party, Big Tech Disappears Doctors - Vimarsana News

Like the Chinese Communist Party, Big Tech Disappears Doctors

At the beginning of the Wuhan coronavirus pandemic, a number of doctors in China sounded the alarm about an unknown, pneumonia-like virus sweeping through the country. Ultimately, it would reach

Researchers receive NIH grants to develop new treatments for neglected tropical diseases - Vimarsana News

Researchers receive NIH grants to develop new treatments for neglected tropical diseases

Researchers at Washington University School of Medicine in St. Louis have received two grants from the National Institutes of Health totaling more than $5.5 million to develop new treatments for two types of devastating parasitic infections common in sub-Saharan Africa and Central and South America: river blindness and intestinal worm infections.